Three Things

June 2011
Pharmaceutical Representative;Jun2011, Vol. 41 Issue 6, p9
The article offers information on three things to ponder on topics related to the pharmaceutical industry in the U.S. including the conflicting interests for medical representatives to get certified, the search of a novel biotechnology enterprise, and the debate on representatives' free speech versus physician privacy.


Related Articles

  • Lower-Cost Alternatives data addresses the rapidly growing, costly Specialty medication market.  // Biomedical Market Newsletter;8/7/2012, Vol. 21, p1 

    The article informs that the company DRX is expanding its coverage of specialty drugs in DrugCompare technology. DRX DrugCompare identifies lower cost drug alternatives for prescription drugs. It also informs that the lower-cost alternatives data in DrugCompare is the most widely-used...

  • Comparative Effectiveness: The Fourth Hurdle in Drug Development and a Role for Clinical Pharmacology. Honig, P. K. // Clinical Pharmacology & Therapeutics;Feb2011, Vol. 89 Issue 2, p151 

    The author reflects on comparative effectiveness as a hurdle for drug development in the U.S., as well as on its role in clinical pharmacology. The author mentions three other challenges to the drug development effort by the pharmaceutical companies in the country such as safety, efficacy, and...

  • For med-tech compliance, several challenges are looming. Iskowitz, Marc // Medical Marketing & Media;Jun2014, Vol. 49 Issue 6, p30 

    The article discusses the challenges posed by medical technology compliance regulations on medical device manufacturers in the U.S. with the release of physician payment data reported by medical technology and biopharma firms.

  • Using HIT to improve access to state-based PDMPs. Gross, Allison; Yap, Diana // Pharmacy Today;April2014, Vol. 20 Issue 4, p61 

    The article reports on the benefits on the use for health information technology (HIT) to improve access to state-based Prescription Drug Monitoring programs (PDMPs) in the U.S.

  • Platform Improves Medication Adherence, Engagement. Goth, Greg // Healthdatamanagement.com;1/15/2015, p1 

    Medication adherence and digital patient engagement vendor HealthPrize says results of several pharmaceutical company-sponsored studies have demonstrated improved patient adherence and engagement using the digital platform.

  • Impax Laboratories Adopts Revitas's Suite.  // Biomedical Market Newsletter;2/28/2012, Vol. 21, p1 

    The article presents information on an announcement made by Revitas Inc. related to the adoption of the company's strategic Flex technology platform by Impax Laboratories Inc. As per Al Smith, president of the company, this relationship is valedictory proof for Enterprise Revenue Dynamics in the...

  • YOUR DRUGS ARE TALKING ABOUT YOU. Maney, Kevin // Newsweek Global;4/25/2014, Vol. 162 Issue 16, p79 

    The article focuses on the development of digitized prescriptions, which allows patients to upload biological data to determine the effectiveness of drug dosages. Topics include the use of personal health trackers alongside prescription drugs, the development of digital monitoring services that...

  • CORPORATE.  // MondayMorning;7/21/2008, Vol. 16 Issue 28, p2 

    The article presents news items related to the pharmaceutical industry in the U.S. The 2008 second-quarter profit of Baxter International Inc. has increased by 26% due to an increase in sales of biotechnology drugs and vaccines. The 2008 second-quarter profit of Abbott Laboratories Inc. has...

  • Technology bytes. Novotney, Amy // McKnight's Long-Term Care News;Oct2015, Vol. 36 Issue 10, p82 

    The article discusses the advancement of electronic prescribing in the U.S. and its ramifications for the long-term care (LTC) sector. Topics covered include the Centers for Medicare & Medicaid Services' (CMS) requirement for LTC operators to adhere to the National Council for Prescription Drug...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics